Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process.
Recent laws may not yet be included in the ILCS database, but they are found on this site as
Public
Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the
Guide.
Because the statute database is maintained primarily for legislative drafting purposes,
statutory changes are sometimes included in the statute database before they take effect.
If the source note at the end of a Section of the statutes includes a Public Act that has
not yet taken effect, the version of the law that is currently in effect may have already
been removed from the database and you should refer to that Public Act to see the changes
made to the current law.
(410 ILCS 27/10) Sec. 10. Prescription to authorized entity; use; training. (a) A health care practitioner may prescribe epinephrine injectors in the name of an authorized entity for use in accordance with this Act, and pharmacists and health care practitioners may dispense epinephrine injectors pursuant to a prescription issued in the name of an authorized entity. Such prescriptions shall be valid for a period of 2 years. (b) An authorized entity may acquire and stock a supply of undesignated epinephrine injectors pursuant to a prescription issued under subsection (a) of this Section. Such undesignated epinephrine injectors shall be stored in a location readily accessible in an emergency and in accordance with the instructions for use of the epinephrine injectors. The Department may establish any additional requirements an authorized entity must follow under this Act. (c) An employee or agent of an authorized entity or other individual who has completed training under subsection (d) of this Section may: (1) provide an epinephrine injector to any individual |
| on the property of the authorized entity whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, or to the parent, guardian, or caregiver of such individual, for immediate administration, regardless of whether the individual has a prescription for an epinephrine injector or has previously been diagnosed with an allergy; or
|
|
(2) administer an epinephrine injector to any
|
| individual on the property of the authorized entity whom the employee, agent, or other individual believes in good faith is experiencing anaphylaxis, regardless of whether the individual has a prescription for an epinephrine injector or has previously been diagnosed with an allergy.
|
|
(d) An employee, agent, or other individual authorized must complete an anaphylaxis training program before he or she is able to provide or administer an epinephrine injector under this Section. Such training shall be valid for a period of 2 years and shall be conducted by a nationally recognized organization experienced in training laypersons in emergency health treatment. The Department shall include links to training providers' websites on its website.
Training shall include, but is not limited to:
(1) how to recognize signs and symptoms of an
|
| allergic reaction, including anaphylaxis;
|
|
(2) how to administer an epinephrine injector; and
(3) a test demonstrating competency of the knowledge
|
| required to recognize anaphylaxis and administer an epinephrine injector.
|
|
Training may also include, but is not limited to:
(A) a review of high-risk areas on the authorized
|
| entity's property and its related facilities;
|
|
(B) steps to take to prevent exposure to allergens;
(C) emergency follow-up procedures; and
(D) other criteria as determined in rules adopted
|
|
Training may be conducted either online or in person. The Department shall approve training programs and list permitted training programs on the Department's Internet website.
(Source: P.A. 99-711, eff. 1-1-17; 100-799, eff. 1-1-19.)
|
